Search Results - "Goeree, Ron A"

Community based intervention to optimize osteoporosis management: randomized controlled trial by Ciaschini, Patricia M, Straus, Sharon E, Dolovich, Lisa R, Goeree, Ron A, Leung, Karen M, Woods, Carol R, Zimmerman, Greg M, Majumdar, Sumit R, Spadafora, Silvana, Fera, Luke A, Lee, Hui N

“…Osteoporosis-related fractures are a significant public health concern. Interventions that increase detection and treatment of osteoporosis are underutilized…”
Get full text

Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada by O'Reilly, Daria J., Xie, Feng, Pullenayegum, Eleanor, Gerstein, Hertzel C., Greb, Janet, Blackhouse, Gord K., Tarride, Jean-Eric, Bowen, Jim, Goeree, Ron A.

“…Objectives The goal of this study was to analyze healthrelated quality of life (HRQL) data from a Canadian population with type 2 diabetes in order to estimate…”
Get full text

Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis by Bhan, Sasha N., Pautler, Stephen E., Shayegan, Bobby, Voss, Maurice D., Goeree, Ron A., You, John J.

“…Background Patients with a cortical small (≤4 cm) renal mass often are not candidates for or choose not to undergo surgery. The optimal management strategy for…”
Get full text

The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06 by O'Reilly, Daria J, Goeree, Ron A, Tarride, Jean-Eric, James, Collen, Parfrey, Patrick S

“…Due to the increasing costs of pharmaceuticals, drug benefit programs often implement various policies that limit availability of drugs. These policies can…”
Get full text

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report by Wolowacz, Sorrel E., PhD, Briggs, Andrew, DPhil, Belozeroff, Vasily, PhD, Clarke, Philip, PhD, Doward, Lynda, MRes, Goeree, Ron, MA, Lloyd, Andrew, DPhil, Norman, Richard, PhD

“…Abstract Cost-utility models are increasingly used in many countries to establish whether the cost of a new intervention can be justified in terms of health…”
Get full text

Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective by Doble, Brett, MSc, Blackhouse, Gord, MSc, Goeree, Ron, MA, Xie, Feng, PhD

“…Objectives The primary analysis estimated the cost-effectiveness of transfemoral transcatheter aortic valve implantation (Edwards SAPIEN heart valve; Edwards…”
Get full text

Introduction to health economics and decision-making: Is economics relevant for the frontline clinician? by Goeree, Ron, MA, Diaby, Vakaramoko, PhD

“…Abstract In a climate of escalating demands for new health care services and significant constraints on new resources, the disciplines of health economics and…”
Get full text

Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate? by Pullenayegum, Eleanor M., PhD, Tarride, Jean-Eric, PhD, Xie, Feng, PhD, Goeree, Ron, MA, Gerstein, Hertzel C., MD, O'Reilly, Daria, PhD

“…Abstract Background Health utility data often show an apparent truncation effect, where a proportion of individuals achieve the upper bound of 1. The Tobit…”
Get full text

A review of the cost of cardiovascular disease by Tarride, Jean-Eric, PhD, Lim, Morgan, MA, DesMeules, Marie, MSc, Luo, Wei, MB MSc, Burke, Natasha, BSc, O’Reilly, Daria, PhD, Bowen, James, BScPhm MSc, Goeree, Ron, MA

“…In Canada, 74,255 deaths (33% of all deaths) in 2003 were due to cardiovascular disease (CVD). As one of the most costly diseases, CVD represents a major…”
Get full text

Systematic Review on the Patient-Reported Outcomes of Tissue-Expander/Implant vs Autologous Abdominal Tissue Breast Reconstruction in Postmastectomy Breast Cancer Patients by Tsoi, Bernice, BSc, MSc, PhD(cand), Ziolkowski, Natalia I., BCom, BSc, MD, Thoma, Achilleas, MD, MSc, FACS, Campbell, Kaitryn, BEd, MLIS, O'Reilly, Daria, BSc, MSc, PhD, Goeree, Ron, BA, MA

Get full text

Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018 by Mackinnon, Erin S., Goeree, Ron, Goodman, Shaun G., Rogoza, Raina M., Packalen, Millicent, Pericleous, Louisa, Motsepe-Ditshego, Ponda, Oh, Paul

“…Cardiovascular disease is the second-leading cause of death in Canada. However, limited data are available on the prevalence of atherosclerotic cardiovascular…”
Get full text

Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications by Ko, Dennis T., MD, MSc, Chiu, Maria, MSc, Guo, Helen, MSc, Austin, Peter C., PhD, Goeree, Ron, MA, Cohen, Eric, MD, Labinaz, Marino, MD, Tu, Jack V., MD, PhD

“…Objectives Our main objective was to evaluate the longer-term safety and efficacy of drug-eluting stents (DES) in off-label indications as compared with…”
Get full text

Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis by von Keyserlingk, Camilla, MA, Hopkins, Robert, MSc, Anastasilakis, Athanasios, MD, Toulis, Konstantinos, MD, Goeree, Ron, MA, Tarride, Jean-Eric, PhD, Xie, Feng, PhD

“…Objective Clinical trials indicate that denosumab could be a potential treatment for postmenopausal osteoporosis. The objective of this meta-analysis was to…”
Get full text

Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada by He, Jing, MHSA, MSc, Bowen, James M., MSc, Xie, Feng, PhD, Goeree, Ron, MA

“…Abstract Objective To conduct a cost-effectiveness analysis of currently available nucleos(t)ide antiviral treatments (lamivudine, telbivudine, entecavir, and…”
Get full text

Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation by Goeree, Ron, MA, Hopkins, Rob, MA, Marshall, John K., MD, MSc, Armstrong, David, MA, MB, Ungar, Wendy J., PhD, Goldsmith, Charles, PhD, Allen, Christopher, Anvari, Mehran, MBBS, PhD

“…Abstract Background Very few randomized controlled trials (RCTs) have compared laparoscopic Nissen fundoplication (LNF) to proton pump inhibitors (PPI) medical…”
Get full text

Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada by Tarride, Jean-Eric, PhD, Blackhouse, Gord, BComm, MBA, MSc, De Rose, Guy, BSc, MD, Novick, Teresa, RN, BA, Bowen, James M., BScPhm, MSc, Hopkins, Robert, BA, BSc, MA, O'Reilly, Daria, PhD, Goeree, Ron, MA

“…Background Abdominal aortic aneurysm (AAA) is a prevalent health condition affecting up to 14% of men and 6% of women. The objective of this study was to…”
Get full text

Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program by Goeree, Ron, MA, von Keyserlingk, Camilla, MA, Burke, Natasha, MA, He, Jing, Kaczorowski, Janusz, PhD, Chambers, Larry, PhD, Dolovich, Lisa, BScPhM, PharmD, Msc, Michael Paterson, J., MSc, Zagorski, Brandon, MS

“…Abstract Background Cardiovascular disease (CVD) is a leading cause of hospitalizations, death, and health care costs. Although studies have shown that…”
Get full text

A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada by Blackhouse, Gord, MSc, MBA, BCom, Hopkins, Robert, BA, BSc, MA, Bowen, James M., BScPhm, MSc, De Rose, Guy, BSc, MD, FRCSC, FACS, Novick, Teresa, RN, BA, Tarride, Jean-Eric, PhD, O'Reilly, Daria, PhD, Xie, Feng, PhD, Goeree, Ron, MA

“…Abstract Objectives The primary risk of abdominal aortic aneurysms (AAAs) is rupture, which is associated with a high mortality rate. Elective surgical options…”
Get full text

Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura by Xie, Feng, PhD, Blackhouse, Gord, MA, Assasi, Nazila, PhD, MD, Campbell, Kaitryn, MLIS, Levin, Mitchell, MD, MSc, Bowen, Jim, MSc, Tarride, Jean-Eric, PhD, Pi, David, MBBS, MBA, Goeree, Ron, MA

“…Abstract Objective : The aim of this work was to estimate the cost-effectiveness of intravenous immunoglobulin (IVIg) compared with oral prednisone as a…”
Get full text

Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario by Goeree, Ron, MA, Chandra, Kiran, MSc, Tarride, Jean-Eric, PhD, O'Reilly, Daria, PhD, Xie, Feng, PhD, Bowen, James, BScPhm, MSc, Blackhouse, Gord, MSc, Hopkins, Robert, MA

“…The Program for Assessment of Technology in Health (PATH) Research Institute is the longest established group undertaking conditionally funded field…”
Get full text